Company
Key Facts
Established in 2021
Founded on breakthrough technology developed at MIT's Research Laboratory of Electronics and Singapore MIT Alliance for Research and Technology.
Partnerships
Partnered with leading healthcare companies and medical research hospitals across the globe, actively forming new strategic partnerships.
Intellectual Property
The intellectual property portfolio includes 2 issued and 5 pending patents focused on microscale magnetic resonance technology for measuring oxidative stress in blood and for life sciences applications.
Peer-Reviewed
19 peer-reviewed publications validating LarmorBio’s importance in clinical diagnostics and life science research.
>5,000 Patients Studied
Currently used in studies worldwide, representing thousands of patients in major disease areas impacting human health.
Management Team
CEO and Founder
Louis Bouchard PhD
CSO
Board of Directors
Glenn Snyder
Board Member
Michael Mcphaul M.D
Chief Medical Officer
Emory Anderson
Board Member
Scientific Advisory Board
Bruce Volpe M.D
Robert Silverman J.D PhD
Yie Hou PhD
Daniel Einhorn M.D
Jongyoon Han PhD
Inventor
Bernhard Boehm M.D
Get exclusive access to our investor deck detailing LarmorBio’s groundbreaking microscale NMR platform, partnerships with global healthcare leaders, and expanding market potential.
